FLUCONAZOLE | N019949 | PFIZER CENTRAL RESEARCH
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Suitability Petition from Senores Pharmaceuticals, Inc FDA-2026-P-7603 · 5 docket documents Senores Pharmaceuticals, Inc. filed a suitability petition under section 505(j)(2)(C) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA declare Fluconazole Tablets 75 mg suitable for submission in an Abbreviated New Drug Application. The proposed 75 mg strength is an intermediate t | Suitability | 2026-07-08 | Open | Senores Pharmaceuticals, Inc |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.